The measurement of cardiac output (CO) is essential in medical practice. In the past, invasive monitoring with a pulmonary artery catheter (PAC) was the gold standard used to measure CO, but in recent years many minimally invasive or non-invasive devices have been developed to measure CO. Cardiac output gives information about tissue perfusion and oxygen delivery and can identify patients who are at high risk of mortality or morbidity.
Strategic insights for the North America Non-Invasive Cardiac Output Monitoring Device provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2020 | US$ 95,471.09 thousand |
Market Size by 2027 | US$ 129,912.44 thousand |
Global CAGR (2020 - 2027) | 5.1% |
Historical Data | 2018-2019 |
Forecast period | 2021-2027 |
Segments Covered |
By Device
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
The geographic scope of the North America Non-Invasive Cardiac Output Monitoring Device refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The North America non-invasive cardiac output monitoring device market is expected to reach US$ 129,912.44 thousand by 2027 from US$ 95,471.09 thousand in 2020; it is expected to grow at a CAGR of 5.1% from 2020 to 2027. The growth of the market is attributed to a few key driving factors such as increase in prevalence of cardiovascular diseases and rise in geriatric population. However, the high cost of the device hinders the market growth.
In recent years, many minimally invasive or non-invasive devices have been developed to measure cardiac output (CO), which is essential in a medical practice. Cardiac output gives information about tissue perfusion and oxygen delivery as well as can identify patients who are at high risk of mortality or morbidity. According to the estimates of the Centers for Disease Control and Prevention (CDC), one person dies every 36 seconds due to cardiovascular diseases (CVD) in the US. Thus, the growing prevalence of CVD is boosting the adoption of non-invasive cardiac output monitoring devices. Similarly, geriatric populations are susceptible to many chronic diseases. Most of them suffer from multiple diseases such as diabetes, heart diseases, and pulmonary diseases and some of them undergo surgeries. Non-invasive cardiac output (CO) monitoring is one of the important modern medical practices used while observing critically ill patients. As per the data from World Population Prospects: the 2019 Revision, one in four people in North America would be aged 65 or more by 2050. Moreover, the number of people aged 80 years and above is projected to increase by three-folds from 143 million in 2019 to 426 million by 2050. Thus, increasing geriatric population favours the growth of the market.
Based on device, the North America non-invasive cardiac output monitoring device market is segmented into patches, wristwatches, and probes & catheters. The probes & catheters segment held the largest share of the market in 2019. However, the wristwatches segment is estimated to register the highest CAGR in the market during the forecast period.
Based on indication, the North America non-invasive cardiac output monitoring device market is segmented into hypertension, coronary diseases, congenital problems, myocardial ischemia and infarction, heart failure, arrhythmias, and others. The hypertension segment held the largest share of the market in 2019. However, the heart failure segment is estimated to register the highest CAGR in the market during the forecast period.
Based on end user, the North America non-invasive cardiac output monitoring device market is segmented into hospitals, emergency services centers, homecare, and others. The hospitals segment held the largest share of the market in 2019. However, the emergency services centers segment is estimated to register the highest CAGR in the market during the forecast period.
Some of the primary and secondary sources associated with this report on the North America non-invasive cardiac output monitoring device market are the U.S Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA) and American Heart Association (AHA).
The North America Non-Invasive Cardiac Output Monitoring Device Market is valued at US$ 95,471.09 thousand in 2020, it is projected to reach US$ 129,912.44 thousand by 2027.
As per our report North America Non-Invasive Cardiac Output Monitoring Device Market, the market size is valued at US$ 95,471.09 thousand in 2020, projecting it to reach US$ 129,912.44 thousand by 2027. This translates to a CAGR of approximately 5.1% during the forecast period.
The North America Non-Invasive Cardiac Output Monitoring Device Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Non-Invasive Cardiac Output Monitoring Device Market report:
The North America Non-Invasive Cardiac Output Monitoring Device Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Non-Invasive Cardiac Output Monitoring Device Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Non-Invasive Cardiac Output Monitoring Device Market value chain can benefit from the information contained in a comprehensive market report.